Effects	NNS	B-NP	O	Other	###	1	Effects	Effects	NNS	NNS	_	0	root	_	_
of	IN	B-PP	O	Other	###	2	of	of	IN	IN	_	7	case	_	_
1	CD	B-NP	O	Other	###	3	1	1	CD	CD	_	7	nummod	_	_
alpha	SYM	B-NP	O	Other	###	4	alpha	alpha	SYM	SYM	_	7	compound	_	_
,	,	O	O	Other	###	5	,	,	,	,	_	7	punct	_	_
25-dihydroxyvitamin	NN	B-NP	O	Other	###	6	25-dihydroxyvitamin	25-dihydroxyvitamin	NN	NN	_	7	dep	_	_
D3	NN	I-NP	O	Other	###	7	D3	D3	NN	NN	_	1	nmod	_	_
on	IN	B-PP	O	Other	###	8	on	on	IN	IN	_	15	case	_	_
the	DT	B-NP	O	Other	###	9	the	the	DT	DT	_	15	det	_	_
human	JJ	I-NP	B-cell_line	Other	###	10	human	human	JJ	JJ	_	15	amod	_	_
chronic	JJ	I-NP	I-cell_line	Other	###	11	chronic	chronic	JJ	JJ	_	15	amod	_	_
myelogenous	JJ	I-NP	I-cell_line	Other	###	12	myelogenous	myelogenous	JJ	JJ	_	15	amod	_	_
leukemia	NN	I-NP	I-cell_line	Other	###	13	leukemia	leukemia	NN	NN	_	15	compound	_	_
cell	NN	I-NP	I-cell_line	Other	###	14	cell	cell	NN	NN	_	15	compound	_	_
line	NN	I-NP	I-cell_line	Other	###	15	line	line	NN	NN	_	1	nmod	_	_
RWLeu-4	NN	I-NP	B-cell_line	Other	###	16	RWLeu-4	RWLeu-4	NN	NN	_	15	dep	_	_
.	.	O	O	Other	###	17	.	.	.	.	_	1	punct	_	_

The	DT	B-NP	O	Other	###	1	The	The	DT	DT	_	2	det	_	_
effects	NNS	I-NP	O	Other	###	2	effects	effects	NNS	NNS	_	36	nsubjpass	_	_
of	IN	B-PP	O	Other	###	3	of	of	IN	IN	_	8	case	_	_
1	CD	B-NP	O	Other	###	4	1	1	CD	CD	_	8	nummod	_	_
alpha	SYM	B-NP	O	Other	###	5	alpha	alpha	SYM	SYM	_	8	compound	_	_
,	,	O	O	Other	###	6	,	,	,	,	_	8	punct	_	_
25-dihydroxyvitamin	NN	B-NP	O	Other	###	7	25-dihydroxyvitamin	25-dihydroxyvitamin	NN	NN	_	8	dep	_	_
D3	NN	I-NP	O	Other	###	8	D3	D3	NN	NN	_	2	nmod	_	_
(	(	O	O	Other	###	9	(	(	(	(	_	10	punct	_	_
VD3	NN	B-NP	O	Other	###	10	VD3	VD3	NN	NN	_	8	appos	_	_
)	)	O	O	Other	###	11	)	)	)	)	_	10	punct	_	_
on	IN	B-PP	O	Other	###	12	on	on	IN	IN	_	13	case	_	_
proliferation	NN	B-NP	O	Other	###	13	proliferation	proliferation	NN	NN	_	2	nmod	_	_
,	,	O	O	Other	###	14	,	,	,	,	_	13	punct	_	_
differentiation	NN	B-NP	O	Other	###	15	differentiation	differentiation	NN	NN	_	13	conj	_	_
,	,	O	O	Other	###	16	,	,	,	,	_	13	punct	_	_
and	CC	O	O	Other	###	17	and	and	CC	CC	_	13	cc	_	_
macromolecular	JJ	B-NP	O	Other	###	18	macromolecular	macromolecular	JJ	JJ	_	19	amod	_	_
synthesis	NN	I-NP	O	Other	###	19	synthesis	synthesis	NN	NN	_	13	conj	_	_
in	IN	B-PP	O	Other	###	20	in	in	IN	IN	_	31	case	_	_
the	DT	B-NP	O	Other	###	21	the	the	DT	DT	_	31	det	_	_
new	JJ	I-NP	O	Other	###	22	new	new	JJ	JJ	_	31	amod	_	_
Philadelphia	NNP	I-NP	B-cell_line	Other	###	23	Philadelphia	Philadelphia	NNP	NNP	_	31	compound	_	_
chromosome	JJ	I-NP	I-cell_line	Other	###	24	chromosome	chromosome	JJ	JJ	_	31	compound	_	_
-	-	O	O	Other	###	25	-	-	-	-	_	31	punct	_	_
positive	JJ	I-NP	I-cell_line	Other	###	26	positive	positive	JJ	JJ	_	31	amod	_	_
chronic	JJ	I-NP	I-cell_line	Other	###	27	chronic	chronic	JJ	JJ	_	31	amod	_	_
myelogenous	JJ	I-NP	I-cell_line	Other	###	28	myelogenous	myelogenous	JJ	JJ	_	31	amod	_	_
leukemia	NN	I-NP	I-cell_line	Other	###	29	leukemia	leukemia	NN	NN	_	31	compound	_	_
cell	NN	I-NP	I-cell_line	Other	###	30	cell	cell	NN	NN	_	31	compound	_	_
line	NN	I-NP	I-cell_line	Other	###	31	line	line	NN	NN	_	13	nmod	_	_
,	,	O	O	Other	###	32	,	,	,	,	_	31	punct	_	_
RWLeu-4	NN	B-NP	B-cell_line	Other	###	33	RWLeu-4	RWLeu-4	NN	NN	_	31	appos	_	_
,	,	O	O	Other	###	34	,	,	,	,	_	2	punct	_	_
were	VBD	B-VP	O	Other	###	35	were	were	VBD	VBD	_	36	auxpass	_	_
investigated	VBN	I-VP	O	Other	###	36	investigated	investigated	VBN	VBN	_	0	root	_	_
.	.	O	O	Other	###	37	.	.	.	.	_	36	punct	_	_

Binding	NN	B-NP	O	Other	###	1	Binding	Binding	NN	NN	_	8	nsubj	_	_
of	IN	B-PP	O	Other	###	2	of	of	IN	IN	_	4	case	_	_
[	(	O	O	Other	###	3	[	[	(	(	_	4	amod	_	_
3H	NN	B-NP	O	Other	###	4	3H	3H	NN	NN	_	1	nmod	_	_
]	)	I-NP	O	Other	###	5	]	]	)	)	_	4	amod	_	_
VD3	NN	I-NP	O	Other	###	6	VD3	VD3	NN	NN	_	5	dobj	_	_
was	VBD	B-VP	O	Other	###	7	was	was	VBD	VBD	_	8	cop	_	_
saturable	JJ	B-ADJP	O	Other	###	8	saturable	saturable	JJ	JJ	_	0	root	_	_
,	,	O	O	Other	###	9	,	,	,	,	_	8	punct	_	_
with	IN	B-PP	O	Other	###	10	with	with	IN	IN	_	13	case	_	_
approximately	RB	B-NP	O	Other	###	11	approximately	approximately	RB	RB	_	12	advmod	_	_
2000-3000	CD	I-NP	O	Other	###	12	2000-3000	2000-3000	CD	CD	_	13	nummod	_	_
sites	NNS	I-NP	O	Other	###	13	sites	sites	NNS	NNS	_	8	nmod	_	_
/	/	O	O	Other	###	14	/	/	/	/	_	13	punct	_	_
cell	NNS	I-NP	O	Other	###	15	cell	cell	NNS	NNS	_	13	dep	_	_
,	,	O	O	Other	###	16	,	,	,	,	_	8	punct	_	_
and	CC	O	O	Other	###	17	and	and	CC	CC	_	8	cc	_	_
half	JJ	B-NP	O	Other	###	18	half	half	JJ	JJ	_	21	amod	_	_
-	-	O	O	Other	###	19	-	-	-	-	_	18	punct	_	_
maximal	JJ	B-NP	O	Other	###	20	maximal	maximal	JJ	JJ	_	21	amod	_	_
binding	NN	I-NP	O	Other	###	21	binding	binding	NN	NN	_	22	nsubj	_	_
occurring	VBG	B-VP	O	Other	###	22	occurring	occurring	VBG	VBG	_	8	conj	_	_
at	IN	B-PP	O	Other	###	23	at	at	IN	IN	_	25	case	_	_
0.21-0.33	CD	B-NP	O	Other	###	24	0.21-0.33	0.21-0.33	CD	CD	_	25	nummod	_	_
nM	NN	I-NP	O	Other	###	25	nM	nM	NN	NN	_	22	nmod	_	_
.	.	O	O	Other	###	26	.	.	.	.	_	8	punct	_	_

Treatment	NN	B-NP	O	Other	###	1	Treatment	Treatment	NN	NN	_	7	nsubj	_	_
of	IN	B-PP	O	Other	###	2	of	of	IN	IN	_	4	case	_	_
RWLeu-4	NN	B-NP	B-cell_line	Other	###	3	RWLeu-4	RWLeu-4	NN	NN	_	4	compound	_	_
cells	NNS	I-NP	I-cell_line	Other	###	4	cells	cells	NNS	NNS	_	1	nmod	_	_
with	IN	B-PP	O	Other	###	5	with	with	IN	IN	_	6	case	_	_
VD3	NN	B-NP	B-protein	Other	###	6	VD3	VD3	NN	NN	_	1	nmod	_	_
induced	VBD	B-VP	O	Other	###	7	induced	induced	VBD	VBD	_	0	root	_	_
24R-hydroxylase	NN	B-NP	B-protein	Other	###	8	24R-hydroxylase	24R-hydroxylase	NN	NN	_	9	compound	_	_
activity	NN	I-NP	O	Other	###	9	activity	activity	NN	NN	_	7	dobj	_	_
,	,	O	O	Other	###	10	,	,	,	,	_	9	punct	_	_
a	DT	B-NP	O	Other	###	11	a	a	DT	DT	_	12	det	_	_
marker	NN	I-NP	O	Other	###	12	marker	marker	NN	NN	_	9	appos	_	_
of	IN	B-PP	O	Other	###	13	of	of	IN	IN	_	16	case	_	_
vitamin	NN	B-NP	O	Other	###	14	vitamin	vitamin	NN	NN	_	16	compound	_	_
D3	NN	I-NP	O	Other	###	15	D3	D3	NN	NN	_	16	compound	_	_
responsiveness	NN	I-NP	O	Other	###	16	responsiveness	responsiveness	NN	NN	_	12	nmod	_	_
in	IN	B-PP	O	Other	###	17	in	in	IN	IN	_	19	case	_	_
many	JJ	B-NP	O	Other	###	18	many	many	JJ	JJ	_	19	amod	_	_
tissues	NNS	I-NP	O	Other	###	19	tissues	tissues	NNS	NNS	_	16	nmod	_	_
.	.	O	O	Other	###	20	.	.	.	.	_	7	punct	_	_

Exposure	NN	B-NP	O	Other	###	1	Exposure	Exposure	NN	NN	_	8	nsubj	_	_
of	IN	B-PP	O	Other	###	2	of	of	IN	IN	_	4	case	_	_
RWLeu-4	NN	B-NP	B-cell_line	Other	###	3	RWLeu-4	RWLeu-4	NN	NN	_	4	compound	_	_
cells	NNS	I-NP	I-cell_line	Other	###	4	cells	cells	NNS	NNS	_	1	nmod	_	_
to	TO	B-PP	O	Other	###	5	to	to	TO	TO	_	6	case	_	_
VD3	NN	B-NP	O	Other	###	6	VD3	VD3	NN	NN	_	1	nmod	_	_
also	RB	B-ADVP	O	Other	###	7	also	also	RB	RB	_	8	advmod	_	_
inhibited	VBD	B-VP	O	Other	###	8	inhibited	inhibited	VBD	VBD	_	0	root	_	_
proliferation	NN	B-NP	O	Other	###	9	proliferation	proliferation	NN	NN	_	8	dobj	_	_
and	CC	I-NP	O	Other	###	10	and	and	CC	CC	_	9	cc	_	_
DNA	NN	I-NP	O	Other	###	11	DNA	DNA	NN	NN	_	12	compound	_	_
synthesis	NN	I-NP	O	Other	###	12	synthesis	synthesis	NN	NN	_	9	conj	_	_
with	IN	B-PP	O	Other	###	13	with	with	IN	IN	_	18	case	_	_
a	DT	B-NP	O	Other	###	14	a	a	DT	DT	_	18	det	_	_
50	CD	I-NP	O	Other	###	15	50	50	CD	CD	_	16	compound	_	_
%	NN	I-NP	O	Other	###	16	%	%	NN	NN	_	18	amod	_	_
effective	JJ	I-NP	O	Other	###	17	effective	effective	JJ	JJ	_	18	amod	_	_
dose	NN	I-NP	O	Other	###	18	dose	dose	NN	NN	_	8	nmod	_	_
of	IN	B-PP	O	Other	###	19	of	of	IN	IN	_	21	case	_	_
3.5-10	CD	B-NP	O	Other	###	20	3.5-10	3.5-10	CD	CD	_	21	nummod	_	_
nM	NN	I-NP	O	Other	###	21	nM	nM	NN	NN	_	18	nmod	_	_
within	IN	B-PP	O	Other	###	22	within	within	IN	IN	_	24	case	_	_
72	CD	B-NP	O	Other	###	23	72	72	CD	CD	_	24	nummod	_	_
h	NN	I-NP	O	Other	###	24	h	h	NN	NN	_	8	nmod	_	_
;	:	O	O	Other	###	25	;	;	:	:	_	8	punct	_	_
in	IN	B-PP	O	Other	###	26	in	in	IN	IN	_	27	case	_	_
addition	NN	B-NP	O	Other	###	27	addition	addition	NN	NN	_	34	nmod	_	_
,	,	O	O	Other	###	28	,	,	,	,	_	34	punct	_	_
protein	NN	B-NP	O	Other	###	29	protein	protein	NN	NN	_	34	nsubjpass	_	_
and	CC	I-NP	O	Other	###	30	and	and	CC	CC	_	29	cc	_	_
RNA	NN	I-NP	O	Other	###	31	RNA	RNA	NN	NN	_	32	compound	_	_
synthesis	NN	I-NP	O	Other	###	32	synthesis	synthesis	NN	NN	_	29	conj	_	_
were	VBD	B-VP	O	Other	###	33	were	were	VBD	VBD	_	34	auxpass	_	_
inhibited	VBN	I-VP	O	Other	###	34	inhibited	inhibited	VBN	VBN	_	8	parataxis	_	_
by	IN	B-PP	O	Other	###	35	by	by	IN	IN	_	37	case	_	_
VD3	NN	B-NP	O	Other	###	36	VD3	VD3	NN	NN	_	37	compound	_	_
treatment	NN	I-NP	O	Other	###	37	treatment	treatment	NN	NN	_	34	nmod	_	_
.	.	O	O	Other	###	38	.	.	.	.	_	8	punct	_	_

Exposure	NN	B-NP	O	Other	###	1	Exposure	Exposure	NN	NN	_	12	nsubj	_	_
of	IN	B-PP	O	Other	###	2	of	of	IN	IN	_	4	case	_	_
RWLeu-4	NN	B-NP	B-cell_line	Other	###	3	RWLeu-4	RWLeu-4	NN	NN	_	4	compound	_	_
cells	NNS	I-NP	I-cell_line	Other	###	4	cells	cells	NNS	NNS	_	1	nmod	_	_
to	TO	B-PP	O	Other	###	5	to	to	TO	TO	_	8	case	_	_
5	CD	B-NP	O	Other	###	6	5	5	CD	CD	_	7	compound	_	_
nM	NN	I-NP	O	Other	###	7	nM	nM	NN	NN	_	8	amod	_	_
VD3	NN	I-NP	O	Other	###	8	VD3	VD3	NN	NN	_	1	nmod	_	_
for	IN	B-PP	O	Other	###	9	for	for	IN	IN	_	11	case	_	_
72	CD	B-NP	O	Other	###	10	72	72	CD	CD	_	11	nummod	_	_
h	NN	I-NP	O	Other	###	11	h	h	NN	NN	_	1	nmod	_	_
caused	VBD	B-VP	O	Other	###	12	caused	caused	VBD	VBD	_	0	root	_	_
50	CD	B-NP	O	Other	###	13	50	50	CD	CD	_	14	nummod	_	_
%	NN	I-NP	O	Other	###	14	%	%	NN	NN	_	12	dobj	_	_
of	IN	B-PP	O	Other	###	15	of	of	IN	IN	_	17	case	_	_
the	DT	B-NP	O	Other	###	16	the	the	DT	DT	_	17	det	_	_
cells	NNS	I-NP	O	Other	###	17	cells	cells	NNS	NNS	_	14	nmod	_	_
to	TO	B-VP	O	Other	###	18	to	to	TO	TO	_	19	mark	_	_
differentiate	VB	I-VP	O	Other	###	19	differentiate	differentiate	VB	VB	_	12	xcomp	_	_
into	IN	B-PP	O	Other	###	20	into	into	IN	IN	_	25	case	_	_
macrophage	NN	B-NP	B-cell_type	Other	###	21	macrophage	macrophage	NN	NN	_	25	compound	_	_
/	/	O	O	Other	###	22	/	/	/	/	_	25	punct	_	_
monocyte	NN	B-NP	B-cell_type	Other	###	23	monocyte	monocyte	NN	NN	_	25	compound	_	_
type	NN	I-NP	I-cell_type	Other	###	24	type	type	NN	NN	_	25	compound	_	_
cells	NNS	I-NP	I-cell_type	Other	###	25	cells	cells	NNS	NNS	_	19	nmod	_	_
as	IN	B-SBAR	O	Other	###	26	as	as	IN	IN	_	27	mark	_	_
judged	VBN	B-VP	O	Other	###	27	judged	judged	VBN	VBN	_	19	advcl	_	_
by	IN	B-PP	O	Other	###	28	by	by	IN	IN	_	31	case	_	_
nitroblue	JJ	B-NP	O	Other	###	29	nitroblue	nitroblue	JJ	JJ	_	31	amod	_	_
tetrazolium	NN	I-NP	O	Other	###	30	tetrazolium	tetrazolium	NN	NN	_	31	compound	_	_
staining	NN	I-NP	O	Other	###	31	staining	staining	NN	NN	_	27	nmod	_	_
and	CC	I-NP	O	Other	###	32	and	and	CC	CC	_	31	cc	_	_
adherence	NN	I-NP	O	Other	###	33	adherence	adherence	NN	NN	_	31	conj	_	_
to	TO	B-PP	O	Other	###	34	to	to	TO	TO	_	35	case	_	_
plastic	NN	B-NP	O	Other	###	35	plastic	plastic	NN	NN	_	33	nmod	_	_
.	.	O	O	Other	###	36	.	.	.	.	_	12	punct	_	_

Progressive	JJ	B-NP	O	Other	###	1	Progressive	Progressive	JJ	JJ	_	2	amod	_	_
expression	NN	I-NP	O	Other	###	2	expression	expression	NN	NN	_	17	nsubjpass	_	_
of	IN	B-PP	O	Other	###	3	of	of	IN	IN	_	6	case	_	_
cell	NN	B-NP	B-protein	Other	###	4	cell	cell	NN	NN	_	6	compound	_	_
surface	NN	I-NP	I-protein	Other	###	5	surface	surface	NN	NN	_	6	compound	_	_
maturation	JJ	I-NP	I-protein	Other	###	6	maturation	maturation	JJ	JJ	_	2	nmod	_	_
-	-	O	O	Other	###	7	-	-	-	-	_	9	punct	_	_
specific	JJ	I-NP	I-protein	Other	###	8	specific	specific	JJ	JJ	_	9	amod	_	_
antigens	NNS	I-NP	I-protein	Other	###	9	antigens	antigens	NNS	NNS	_	2	nmod	_	_
of	IN	B-PP	O	Other	###	10	of	of	IN	IN	_	15	case	_	_
the	DT	B-NP	O	Other	###	11	the	the	DT	DT	_	15	det	_	_
monocyte	NN	I-NP	B-cell_type	Other	###	12	monocyte	monocyte	NN	NN	_	15	compound	_	_
/	/	O	O	Other	###	13	/	/	/	/	_	15	punct	_	_
macrophage	NN	I-NP	B-cell_type	Other	###	14	macrophage	macrophage	NN	NN	_	15	compound	_	_
lineage	NN	I-NP	I-cell_type	Other	###	15	lineage	lineage	NN	NN	_	9	nmod	_	_
was	VBD	B-VP	O	Other	###	16	was	was	VBD	VBD	_	17	auxpass	_	_
induced	VBN	I-VP	O	Other	###	17	induced	induced	VBN	VBN	_	0	root	_	_
by	IN	B-PP	O	Other	###	18	by	by	IN	IN	_	19	case	_	_
treatment	NN	B-NP	O	Other	###	19	treatment	treatment	NN	NN	_	17	nmod	_	_
of	IN	B-PP	O	Other	###	20	of	of	IN	IN	_	22	case	_	_
RWLeu-4	NN	B-NP	B-cell_line	Other	###	21	RWLeu-4	RWLeu-4	NN	NN	_	22	compound	_	_
cells	NNS	I-NP	I-cell_line	Other	###	22	cells	cells	NNS	NNS	_	19	nmod	_	_
with	IN	B-PP	O	Other	###	23	with	with	IN	IN	_	24	case	_	_
VD3	NN	B-NP	O	Other	###	24	VD3	VD3	NN	NN	_	19	nmod	_	_
for	IN	B-PP	O	Other	###	25	for	for	IN	IN	_	29	case	_	_
24	CD	B-NP	O	Other	###	26	24	24	CD	CD	_	28	compound	_	_
to	TO	I-NP	O	Other	###	27	to	to	TO	TO	_	28	dep	_	_
72	CD	I-NP	O	Other	###	28	72	72	CD	CD	_	29	nummod	_	_
h	NN	I-NP	O	Other	###	29	h	h	NN	NN	_	17	nmod	_	_
at	IN	B-PP	O	Other	###	30	at	at	IN	IN	_	31	case	_	_
doses	NNS	B-NP	O	Other	###	31	doses	doses	NNS	NNS	_	17	nmod	_	_
that	WDT	B-NP	O	Other	###	32	that	that	WDT	WDT	_	33	nsubj	_	_
inhibited	VBD	B-VP	O	Other	###	33	inhibited	inhibited	VBD	VBD	_	31	acl:relcl	_	_
cellular	JJ	B-NP	O	Other	###	34	cellular	cellular	JJ	JJ	_	35	amod	_	_
proliferation	NN	I-NP	O	Other	###	35	proliferation	proliferation	NN	NN	_	33	dobj	_	_
.	.	O	O	Other	###	36	.	.	.	.	_	17	punct	_	_

c-myc	NN	B-NP	B-RNA	B-Protein	###	1	c-myc	c-myc	NN	NN	_	2	compound	_	_
RNA	NN	I-NP	I-RNA	Other	###	2	RNA	RNA	NN	NN	_	12	nsubj	_	_
,	,	O	O	Other	###	3	,	,	,	,	_	2	punct	_	_
which	WDT	B-NP	O	Other	###	4	which	which	WDT	WDT	_	7	nsubjpass	_	_
is	VBZ	B-VP	O	Other	###	5	is	is	VBZ	VBZ	_	7	auxpass	_	_
constitutively	RB	I-VP	O	Other	###	6	constitutively	constitutively	RB	RB	_	7	advmod	_	_
expressed	VBN	I-VP	O	Other	###	7	expressed	expressed	VBN	VBN	_	2	acl:relcl	_	_
in	IN	B-PP	O	Other	###	8	in	in	IN	IN	_	10	case	_	_
RWLeu-4	NN	B-NP	B-cell_line	Other	###	9	RWLeu-4	RWLeu-4	NN	NN	_	10	compound	_	_
cells	NNS	I-NP	I-cell_line	Other	###	10	cells	cells	NNS	NNS	_	7	nmod	_	_
,	,	O	O	Other	###	11	,	,	,	,	_	2	punct	_	_
increased	VBD	B-VP	O	Other	###	12	increased	increased	VBD	VBD	_	0	root	_	_
after	IN	B-PP	O	Other	###	13	after	after	IN	IN	_	15	case	_	_
0.5	CD	B-NP	O	Other	###	14	0.5	0.5	CD	CD	_	15	nummod	_	_
h	NN	I-NP	O	Other	###	15	h	h	NN	NN	_	12	nmod	_	_
of	IN	B-PP	O	Other	###	16	of	of	IN	IN	_	17	case	_	_
treatment	NN	B-NP	O	Other	###	17	treatment	treatment	NN	NN	_	15	nmod	_	_
with	IN	B-PP	O	Other	###	18	with	with	IN	IN	_	21	case	_	_
50	CD	B-NP	O	Other	###	19	50	50	CD	CD	_	20	compound	_	_
nM	NN	I-NP	O	Other	###	20	nM	nM	NN	NN	_	21	amod	_	_
VD3	NN	I-NP	O	Other	###	21	VD3	VD3	NN	NN	_	17	nmod	_	_
and	CC	O	O	Other	###	22	and	and	CC	CC	_	12	cc	_	_
then	RB	O	O	Other	###	23	then	then	RB	RB	_	12	advmod	_	_
rapidly	RB	B-ADVP	O	Other	###	24	rapidly	rapidly	RB	RB	_	12	advmod	_	_
decreased	VBD	B-VP	O	Other	###	25	decreased	decreased	VBD	VBD	_	12	dep	_	_
to	TO	B-PP	O	Other	###	26	to	to	TO	TO	_	29	case	_	_
barely	RB	B-NP	O	Other	###	27	barely	barely	RB	RB	_	28	advmod	_	_
detectable	JJ	I-NP	O	Other	###	28	detectable	detectable	JJ	JJ	_	29	amod	_	_
levels	NNS	I-NP	O	Other	###	29	levels	levels	NNS	NNS	_	25	nmod	_	_
after	IN	B-PP	O	Other	###	30	after	after	IN	IN	_	32	case	_	_
4	CD	B-NP	O	Other	###	31	4	4	CD	CD	_	32	nummod	_	_
h	NN	I-NP	O	Other	###	32	h	h	NN	NN	_	25	nmod	_	_
of	IN	B-PP	O	Other	###	33	of	of	IN	IN	_	34	case	_	_
treatment	NN	B-NP	O	Other	###	34	treatment	treatment	NN	NN	_	32	nmod	_	_
.	.	O	O	Other	###	35	.	.	.	.	_	12	punct	_	_

Finally	RB	B-ADVP	O	Other	###	1	Finally	Finally	RB	RB	_	16	advmod	_	_
,	,	O	O	Other	###	2	,	,	,	,	_	16	punct	_	_
the	DT	B-NP	O	Other	###	3	the	the	DT	DT	_	8	det	_	_
in	FW	I-NP	O	Other	###	4	in	in	FW	FW	_	8	amod	_	_
vitro	FW	I-NP	O	Other	###	5	vitro	vitro	FW	FW	_	4	dep	_	_
tyrosine	NN	I-NP	B-protein	Other	###	6	tyrosine	tyrosine	NN	NN	_	8	compound	_	_
kinase	NN	I-NP	I-protein	Other	###	7	kinase	kinase	NN	NN	_	8	compound	_	_
activity	NN	I-NP	O	Other	###	8	activity	activity	NN	NN	_	16	nsubjpass	_	_
associated	VBN	B-VP	O	Other	###	9	associated	associated	VBN	VBN	_	8	acl	_	_
with	IN	B-PP	O	Other	###	10	with	with	IN	IN	_	14	case	_	_
the	DT	B-NP	O	Other	###	11	the	the	DT	DT	_	14	det	_	_
p210bcr-abl	NN	I-NP	B-protein	B-Protein	###	12	p210bcr-abl	p210bcr-abl	NN	NN	_	14	compound	_	_
oncogene	NN	I-NP	I-protein	I-Protein	###	13	oncogene	oncogene	NN	NN	_	14	compound	_	_
product	NN	I-NP	I-protein	Other	###	14	product	product	NN	NN	_	9	nmod	_	_
was	VBD	B-VP	O	Other	###	15	was	was	VBD	VBD	_	16	auxpass	_	_
decreased	VBN	I-VP	O	Other	###	16	decreased	decreased	VBN	VBN	_	0	root	_	_
approximately	RB	B-NP	O	Other	###	17	approximately	approximately	RB	RB	_	18	advmod	_	_
50	CD	I-NP	O	Other	###	18	50	50	CD	CD	_	19	nummod	_	_
%	NN	I-NP	O	Other	###	19	%	%	NN	NN	_	16	dobj	_	_
by	IN	B-PP	O	Other	###	20	by	by	IN	IN	_	22	case	_	_
VD3	NN	B-NP	O	Other	###	21	VD3	VD3	NN	NN	_	22	compound	_	_
treatment	NN	I-NP	O	Other	###	22	treatment	treatment	NN	NN	_	16	nmod	_	_
.	.	O	O	Other	###	23	.	.	.	.	_	16	punct	_	_

Because	IN	B-PP	O	Other	###	1	Because	Because	IN	IN	_	4	case	_	_
of	IN	I-PP	O	Other	###	2	of	of	IN	IN	_	1	mwe	_	_
the	DT	B-NP	O	Other	###	3	the	the	DT	DT	_	4	det	_	_
presence	NN	I-NP	O	Other	###	4	presence	presence	NN	NN	_	24	nmod	_	_
of	IN	B-PP	O	Other	###	5	of	of	IN	IN	_	11	case	_	_
a	DT	B-NP	O	Other	###	6	a	a	DT	DT	_	11	det	_	_
functional	JJ	I-NP	O	Other	###	7	functional	functional	JJ	JJ	_	11	amod	_	_
receptor	NN	I-NP	O	Other	###	8	receptor	receptor	NN	NN	_	11	compound	_	_
-	-	O	O	Other	###	9	-	-	-	-	_	11	punct	_	_
effector	NN	I-NP	O	Other	###	10	effector	effector	NN	NN	_	11	compound	_	_
system	NN	I-NP	O	Other	###	11	system	system	NN	NN	_	4	nmod	_	_
for	IN	B-PP	O	Other	###	12	for	for	IN	IN	_	13	case	_	_
VD3	NN	B-NP	O	Other	###	13	VD3	VD3	NN	NN	_	11	nmod	_	_
and	CC	O	O	Other	###	14	and	and	CC	CC	_	11	cc	_	_
multiple	JJ	B-NP	O	Other	###	15	multiple	multiple	JJ	JJ	_	17	amod	_	_
biological	JJ	I-NP	O	Other	###	16	biological	biological	JJ	JJ	_	17	amod	_	_
responses	NNS	I-NP	O	Other	###	17	responses	responses	NNS	NNS	_	11	conj	_	_
to	TO	B-PP	O	Other	###	18	to	to	TO	TO	_	20	case	_	_
the	DT	B-NP	O	Other	###	19	the	the	DT	DT	_	20	det	_	_
hormone	NN	I-NP	O	Other	###	20	hormone	hormone	NN	NN	_	17	nmod	_	_
,	,	O	O	Other	###	21	,	,	,	,	_	24	punct	_	_
these	DT	B-NP	O	Other	###	22	these	these	DT	DT	_	23	det	_	_
cells	NNS	I-NP	O	Other	###	23	cells	cells	NNS	NNS	_	24	nsubj	_	_
provide	VBP	B-VP	O	Other	###	24	provide	provide	VBP	VBP	_	0	root	_	_
a	DT	B-NP	O	Other	###	25	a	a	DT	DT	_	28	det	_	_
unique	JJ	I-NP	O	Other	###	26	unique	unique	JJ	JJ	_	28	amod	_	_
model	NN	I-NP	O	Other	###	27	model	model	NN	NN	_	28	compound	_	_
system	NN	I-NP	O	Other	###	28	system	system	NN	NN	_	24	dobj	_	_
with	IN	B-PP	O	Other	###	29	with	with	IN	IN	_	30	case	_	_
which	WDT	B-NP	O	Other	###	30	which	which	WDT	WDT	_	32	nmod	_	_
to	TO	B-VP	O	Other	###	31	to	to	TO	TO	_	32	mark	_	_
probe	VB	I-VP	O	Other	###	32	probe	probe	VB	VB	_	28	acl:relcl	_	_
the	DT	B-NP	O	Other	###	33	the	the	DT	DT	_	35	det	_	_
specific	JJ	I-NP	O	Other	###	34	specific	specific	JJ	JJ	_	35	amod	_	_
effects	NNS	I-NP	O	Other	###	35	effects	effects	NNS	NNS	_	32	dobj	_	_
of	IN	B-PP	O	Other	###	36	of	of	IN	IN	_	37	case	_	_
VD3	NN	B-NP	O	Other	###	37	VD3	VD3	NN	NN	_	35	nmod	_	_
on	IN	B-PP	O	Other	###	38	on	on	IN	IN	_	39	case	_	_
cell	NN	B-NP	O	Other	###	39	cell	cell	NN	NN	_	35	nmod	_	_
growth	NN	B-NP	O	Other	###	40	growth	growth	NN	NN	_	39	dep	_	_
and	CC	O	O	Other	###	41	and	and	CC	CC	_	39	cc	_	_
differentiation	NN	B-NP	O	Other	###	42	differentiation	differentiation	NN	NN	_	40	conj	_	_
in	IN	B-PP	O	Other	###	43	in	in	IN	IN	_	46	case	_	_
chronic	JJ	B-NP	O	Other	###	44	chronic	chronic	JJ	JJ	_	46	amod	_	_
myelogenous	JJ	I-NP	O	Other	###	45	myelogenous	myelogenous	JJ	JJ	_	46	amod	_	_
leukemia	NN	I-NP	O	Other	###	46	leukemia	leukemia	NN	NN	_	39	nmod	_	_
.	.	O	O	Other	###	47	.	.	.	.	_	24	punct	_	_

